AMC vs CNK: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AMC and CNK share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AMC and CNK exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

AMC Entertainment Holdings, Inc. (NYSE: AMC), headquartered in Leawood, Kansas, is the largest movie-theater exhibitor in the United States and the world, operating theatres across the U.S. and Europe under the AMC, Odeon, and other banners. The company makes money primarily from box-office admissions and from high-margin food and beverage sales, supplemented by on-screen advertising and premium formats. Its results are tightly tied to the strength of the theatrical film slate: a strong year of major releases lifts attendance and revenue, while a thin or delayed slate (as during the pandemic and the 2023 Hollywood strikes) can sharply reduce both. Full-year 2025 revenue was approximately $2.25 billion on attendance of roughly 104.7 million guests, and Q1 2026 revenue grew approximately 21% year over year to about $1.05 billion as the recovery continued.

Full AMC guide

Cinemark Holdings operates roughly 500 theaters with more than 5,500 screens across 42 US states and 13 countries in South and Central America, making it one of the largest theatrical exhibitors in the world. It earns money primarily from ticket admissions and from high-margin concessions (popcorn, drinks, snacks), supplemented by screen advertising, premium formats like XD, its Movie Club loyalty subscription, and theater rentals. Concessions are central to the economics because they carry far higher margins than the box office split shared with studios.

Full CNK guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• AMC drivers: Box-Office Recovery and Film Slate; Premium Formats and Concessions.
• CNK drivers: Box-office recovery and a fuller release slate; Concessions and premium formats lift per-guest economics.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The dominant risk is the balance sheet: AMC carried roughly $4 billion in corporate borrowings (and a larger total-debt figure including leases) against a few hundred million dollars of cash and a stockholders' deficit as of early 2026, so interest costs and refinancing needs weigh heavily on the equity. For CNK, cinemark's results are highly dependent on a hit-driven, unpredictable film slate, and a weak stretch of releases can quickly pressure attendance and cash flow.

Pick AMC if you believe its drivers more; CNK if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AMC and CNK guides.

AMC. AMC's valuation is unusual because the equity story is driven heavily by debt and dilution rather than by a simple multiple of earnings. The company is not consistently profitable on a net-income basis (it reported net losses in 2025 and Q1 2026), so traditional price-to-earnings metrics are not meaningful; instead, the relevant lens is enterprise value relative to a recovering but still-negative free cash flow, against roughly $4 billion of corporate borrowings and a stockholders' deficit. Because shares outstanding have grown into the hundreds of millions, the market capitalization is spread across far more shares than a few years ago, so any operating improvement must be weighed against ongoing dilution. The stock's price has also historically reflected retail sentiment and short interest tied to its meme-stock status, which can decouple it from fundamentals in both directions.

CNK. As of May 2026 Cinemark traded around a P/E in the mid-20s, roughly $30 per share, reflecting a recovered but cyclical earnings base. The valuation embeds expectations for a strong 2026 slate, while the sizable debt load and hit-driven revenue keep the risk profile elevated relative to steadier consumer names. Figures are approximate and change with market conditions.

Headline figures (approximate, 2026-06-27): AMC shows revenue (fy2025) ~$2.25 billion (up ~14% YoY), revenue (q1 2026) ~$1.05 billion (up ~21% YoY), attendance (fy2025) ~104.7 million guests (up ~8% YoY), net loss (q1 2026) ~$117 million (narrowed from ~$202 million); CNK shows revenue (fy 2025) ~$3.12B, q1 2026 revenue ~$643M (up ~19% YoY), net income (fy 2025) ~$138M (~$1.04 diluted EPS), adjusted ebitda (fy 2025) ~$578M (~18.6% margin).

AMC and CNK are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AMC and CNK exposure against your real portfolio. It is not an investment adviser.